Summary:
Experience Moderate to Severe Ulcerative Colitis?
If so, you may qualify for a clinical research study of an investigational drug for ulcerative colitis at Global Medical Research.
Qualified Participants Must:
• Have moderate to severe ulcerative colitis (UC) and*:
- Be age 18-80
- Have a diagnosis of UC for two or more months prior to joining the study
- Are not satisfied with your response to one of the following types of treatment during the past five years:
- Immunomodulators
- TNF-&alpha (alpha) antagonists
- Corticosteroids
*Other conditions may apply. You cannot participate if you have a history of Crohns disease, indeterminate colitis, or the presence or history of fistula consistent with Crohns disease.
Qualified Participants May Receive:
Qualified participants receive:
- Study-related drug at no cost
- Study-related medical exams at no cost
- Compensation for time and travel